The MEDNAX Center for Research, Education, Quality and Safety (CREQS) empowers health care providers to take great care of the patient, every day and in every way. As part of our ongoing commitment to improving patient care through evidence-based medicine, we engage in clinical research, education, continuous quality improvement and safety initiatives. Our efforts contribute to better patient outcomes and reduced long-term health system costs, not only for our patients and hospital partners, but for all patients and providers across our specialty areas.

Research

To help facilitate and support research efforts, MEDNAX established a Research Advisory Committee (RAC). The goal of the RAC is to design, implement and maintain a program for clinical research oversight and support that enables our practices to conduct research that is safe, effective, financially viable and legally compliant, while optimizing research opportunities. The RAC’s multi-disciplinary approach involves the collaboration of both clinical and business professionals, including finance, legal and compliance experts, and has ultimately enhanced our research efforts and improved overall process flow.

With participating clinicians located throughout the country, the RAC supports a comprehensive scope of research efforts, allowing for a more in-depth look at our specialties. This nationwide perspective allows us to better anticipate future needs and opportunities.

Learn more about current research trials:

Anesthesiology

Pain Management in Response to Exparel vs. Standard Bupivicaine (VATS Exparel)
Exparel provides local anesthesia pain management for up to 72-hours post injection. This trial aims to compare patient outcomes when given Exparel versus bupivacaine after a thorascopy. Patients will be evaluated at seven and 30 days post-procedure to assess pain levels, how much pain medication was consumed and track outcomes.

Maternal-Fetal Medicine

Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes (ACSinPROM)
Women who are pregnant with a singleton within a certain gestation range and experiencing premature rupture of membranes are given a second course of antenatal steroids. This trial looks to discover the impact of a booster course of antenatal steroids on neonatal morbidities, including respiratory distress syndrome.

Non-Invasive Screening for Fetal Aneuploidy
An observational study of the detection of whole chromosome abnormalities and other major defects and deletions through fetal DNA extracted from maternal blood samples.

Vaginal Pessary Versus Expectant Management for Placenta Previa
A comparison of the effectiveness of expectant management versus use of a vaginal pessary in women experiencing preterm placenta previa, with intention of prolonging gestation to 36 weeks or greater. Additional assessments look at maternal and neonatal outcomes post-delivery.

Neonatology

Registry for Severe ROP and Treatment on Visual Outcomes
Improved survival rates of very low birth weight infants have led to increased cases of severe retinopathy of prematurity. This observational study looks to evaluate the visual outcomes of these patients over an extended period of time in association with the therapies and medications used to treat the condition.

Human Milk Feeding Rates Post-NICU Discharge
Data continues to show benefits of human milk use for the medically fragile NICU population. This study is to identify the incentives and barriers to human milk use and breastfeeding post-NICU discharge, with intention of defining better methods of promoting higher rates and prolonged duration.

PDA Post NICU Discharge (PDA)
Varying treatment options are available for premature infants with patent ductus arteriosus (PDA). This post-discharge study follows NICU patients discharged with PDA, tracking spontaneous closure rates and incidences of pulmonary and/or cardiac events to identify risk factors associated with adverse outcomes.

Pediatric Cardiology

Long QT and Hearing Loss Registry
This observational study follows neonatal patients greater than one week of age diagnosed with unilateral or bilateral sensorineural hearing loss to determine the true incidence of long QT. The goal of the study is to determine the incidence of an abnormal ECG and the percentages of these patients with an identifiable genetic mutation as well as patients with an abnormal genetic mutation regardless of the ECG.

Access articles published by MEDNAX clinicians.

Search Database

Education

Our commitment to clinical and research excellence is evidenced by our comprehensive educational and professional development opportunities offered online or during live sessions. We continue to be an ACCME accredited provider of medical and nursing continued education and aim to expand our learning materials to new sub-specialties.
 
Each year, thousands of health care providers worldwide take advantage of educational programs hosted by MEDNAX. The number of clinicians nationally and internationally who participate in these activities is evidence of the depth and breadth of our clinical expertise and position as an industry leader.

Online Education

Available not just for our clinicians, but all of our peers in the medical community, we continuously develop free online education activities available in video and podcast formats.

Quality and Safety

Through the leadership of our affiliated clinicians and with the support of our CREQS, we have cultivated a culture of continuous quality improvement and safety. The culture we have established is the cornerstone of our success and helps us fulfill our mission. Our team of clinical experts leads and provides oversight for several national quality and safety programs in various subspecialties.

Learn more:

National Quality Improvement Collaboratives

National Opioid Management Collaborative (NOPC) – The MEDNAX NOPC addresses the diagnosis, treatment and management of Neonatal Abstinence Syndrome, as well as other key contributing factors such as managing opioid addiction in pregnancy and responsible prescribing practices in the perinatal period.

Specialty Quality Improvement Collaboratives

Neonatology

MEDNAX NICU Breakthrough Collaborative

Achieving optimal outcomes in the practice of neonatal intensive care is challenging and complex. The MEDNAX NICU Breakthrough Collaborative provides support for 100+ participating NICUs striving to improve a variety of neonatal outcomes, including mortality, late onset sepsis, NEC, bronchopulmonary dysplasia, intraventricular hemorrhage and more.

MFM/Perinatal

Enhanced Recovery after Cesarean (ERAC) Collaborative

Enhanced recovery after surgery programs have demonstrated value by improving health outcomes and patient satisfaction while reducing costs. Our ERAC Collaborative gives our affiliated practices and hospital partners tools to assess need and implement ERAC programs.

Best Practices: Amniotic Fluid Volume Assessment Collaborative

The Amniotic Fluid Volume Assessment Collaborative will help our affiliated maternal-fetal medicine practices establish consensus and minimize clinical variations in the definitions and management of abnormal amniotic fluid volume.

ACOG SCOPE Certification Collaborative

The importance of safety is self-evident but the application process to achieve the ACOG Safety Certification of Outpatient Practice Excellence (SCOPE) can be challenging. The ACOG SCOPE Certification Collaborative helps our affiliated practices develop an operations safety manual addressing the content areas required in the SCOPE application.

Shared MFM Content Repository Collaborative

To minimize duplication of efforts and promote best practices in operations and patient education, the Shared MFM Content Repository Collaborative promotes document sharing, including patient instructions, checklists, orders sets and more, among our affiliated practices.

Qualified Clinical Data Registry

The Centers for Medicare and Medicaid Services (CMS) has approved the MEDNAX QCDR as a Qualified Clinical Data Registry (QCDR). MEDNAX clinicians use the MEDNAX QCDR for submitting MIPS and QCDR quality measures and improvement activities to CMS. MEDNAX provides QCDR services without additional cost to MEDNAX-affiliated clinicians.

For 2019, in addition to its CMS MIPS measures (51), MEDNAX includes the following QCDR measures in its QCDR:

For more information about how to participate in the MEDNAX QCDR, please contact Wendy Fountain or David Kanter, MD.

Simulation

Practicing critical decision-making, communication, task and teamwork skills with in situ scenarios promotes optimized clinical performance for high-risk, low-volume critical situations. To meet the needs of our health care providers, hospital and ASC partners, as well as our patients MEDNAX offers a variety of customized simulation programs to instill competence and confidence with one goal in mind: improved outcomes. Our Simulation Program has gained provisional accreditation by the Society for Simulation in Healthcare, a required first step towards attaining full accreditation, and currently offers highly interactive programs for neonatology, anesthesiology and hospital-based medicine practices.

Learn more: simulation@mednax.com

HRO Safety Pathway Program

Crew Resource Management (CRM) training forms the foundation of our High Reliability Organization (HRO) Patient Safety Initiative. We have adopted CRM strategies – proven to optimize safety in aviation and aeronautics industries – to become an HRO so our health care providers can deliver the safest care while communicating efficiently and effectively. MEDNAX has implemented HRO programs across the continuum of care, including our anesthesia and critical care specialties, and as women’s and children’s service lines.

Learn more: creqs@mednax.com

Comprehensive ERAS Program

International experience and evidence-based practice have proven that reduced variability and perioperative care protocols improve surgical outcomes and reduce cost in patients undergoing surgery. Our Comprehensive ERAS program gives affiliated practices the tools they need to establish pre-, intra- and post-operative protocols in partnership with surgical and hospital partners, and assess impact.

Learn more: creqs@mednax.com

Innovation

Collaborative innovation is the pathway towards excellence in research, education, quality and safety. Because of the critical role innovation plays, our team strives to integrate the latest technological advances, artificial or augmented intelligence, genetic discoveries and mobile applications, into every day care. Tele-and mobile health, virtual reality, next generation sequencing, point-of-care diagnostics, advanced data analytics are currently shaping the future of medicine. Our team is actively engaged in designing projects that will allow us to prevent disease, offer precision care and further optimize patient outcomes.

Learn more

Advocacy

To promote our public policy efforts at both the state and national levels, MEDNAX’s Government Relations team collaborates with physician groups, professional societies and hospital partners to safeguard access to care for clinical services.

Learn more



More in Education:

Find a Clinician Find a Practice Request for Proposal